APC c.388_389delinsGC ;(p.S130A)

Variant ID: 5-112103053-AG-GC

NM_000038.5(APC):c.388_389delinsGC;(p.S130A)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


CDK1-dependent inhibition of the E3 ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis.

The Journal Of Biological Chemistry
Rizzardi, Lindsay F LF; Coleman, Kate E KE; Varma, Dileep D; Matson, Jacob P JP; Oh, Seeun S; Cook, Jeanette Gowen JG
Publication Date: 2015-01-02

Variant appearance in text: APC: S130A
PubMed Link: 25411249
Variant Present in the following documents:
  • Main text
View BVdb publication page



CDK4 T172 phosphorylation is central in a CDK7-dependent bidirectional CDK4/CDK2 interplay mediated by p21 phosphorylation at the restriction point.

Plos Genetics
Bisteau, Xavier X; Paternot, Sabine S; Colleoni, Bianca B; Ecker, Karin K; Coulonval, Katia K; De Groote, Philippe P; Declercq, Wim W; Hengst, Ludger L; Roger, Pierre P PP
Publication Date: 2013-05

Variant appearance in text: APC: S130A
PubMed Link: 23737759
Variant Present in the following documents:
  • Main text
View BVdb publication page



Glycogen synthase kinase 3- and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement.

Molecular And Cellular Biology
Cai, Xinming X; Li, Min M; Vrana, Julie J; Schaller, Michael D MD
Publication Date: 2006-04

Variant appearance in text: APC: S130A
PubMed Link: 16537926
Variant Present in the following documents:
  • Main text
View BVdb publication page